AZD7745 targets a conserved ClfA epitope, offering broad neutralization across diverse Staphylococcus aureus strains.

In the ongoing battle against antibiotic-resistant bacteria, MSU researchers have made a discovery that could reshape how we target deadly pathogens like staph infections.

Among the study group, 3,369 patients (67.3%) were SA carriers. Out of those patients, 100 developed a staph SSI or BSI, 86% of whom were colonized with SA, according to the study.